Imatron Announces First Mobile EBT Scanner Sale to
EBT Mobile Scanners Northwest, LLC
Tuesday September 5, 8:17 am Eastern Time
Press Release
Represents Sixth EBT Scanner Sale in Third Quarter
SO. SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sept. 5, 2000- Imatron Inc. (Nasdaq:IMAT - news) announced today that it has sold the Company's first mobile Electron Beam Tomography (EBT) scanner to EBT Mobile Scanners Northwest, LLC, headquartered in Mission Viejo, California, and partnered with the Heart Institute of the Cascades at St. Charles Medical Center in Bend, Oregon. This mobile system sale will be recorded in the Company's third quarter financial results and represents the sixth EBT scanner sale to date during the quarter.
EBT Mobile Scanners Northwest, LLC, in partnership with St. Charles Medical Center in Bend, Oregon, will offer mobile EBT services to a variety of healthcare providers in the Pacific Northwest. Services provided will include coronary artery scanning, lung scanning and electron beam angiography (EBA).
Samuel J. Camarata, MD, CEO of EBT Mobile Scanners Northwest, LLC, stated, ``We are pleased to bring the first mobile EB scanner to Bend, Oregon and the communities of the Pacific Northwest. Our organization has placed an order for the second mobile unit manufactured by Imatron. We expect delivery of the second unit in the October-November 2000 timeframe. Spreading the cost of this significant capital investment among various healthcare providers allows us to make this unique technology available to many smaller communities whose medical facilities do not yet have access to an EBT scanner. We look forward to expanding our mobile EBT business nationwide.''
Bruce H. Brundage, MD, Medical Director and world renowned expert in the development of clinical applications of EBT in the diagnosis of coronary heart disease, stated, ``I am looking forward to bringing EBT technology to the medical communities of the Pacific Northwest. We are providing many people with an opportunity to access this life-saving technology and believe that our mobile EBT business will provide a significant benefit to medical communities nationwide.''
Rick Martin, Senior Vice President of Operations at St. Charles Medical Center, said, ``We are extremely pleased to partner with the country's first mobile EBT provider, EBT Mobile Scanners Northwest, LLC, to make EBT technology available to communities that do not have access to an EBT scanner. Mobile EBT provides a feasible alternative for a smaller medical center to participate in offering this significant and vitally important service to its community.''
S. Lewis Meyer, CEO of Imatron, commented, ``Imatron is pleased to announce this sale of our first mobile EBT scanner to EBT
Mobile Scanners Northwest, LLC. The principals in this venture bring a wealth of experience in providing shared medical services to a broad range of healthcare providers. Imatron's engineering and customer service team has thoroughly and successfully tested this 'state-of-the-art' turnkey mobile EBT system. We believe that our entry into the mobile imaging marketplace represents a
major opportunity for future Imatron EBT scanner sales. With approximately 700 mobile MRI systems now in service across the
United States, the business model, based on sharing the significant capital cost of advanced medical imaging equipment among
multiple users, has clearly proven to be a successful and widely replicated one. Imatron's sales momentum continues to accelerate
and we would expect that our participation in developing and pursuing new market opportunities for our proprietary EBT
technology will further increase sales and profitability.''
For additional information about Imatron, visit the Company's web site at www.imatron.com.
Imatron Inc. is primarily engaged in designing, manufacturing, marketing, and supporting high performance electron beam
tomography (EBT) scanners based on the Company's proprietary EBT technology. Imatron's EBT scanner is now in use at more
than 130 major medical facilities and imaging centers around the world, including the Mayo Clinic, Cedars-Sinai Medical Center,
Abbott-Northwestern Hospital, Mount Sinai Medical Center, University of Iowa, National Institutes of Health, UCLA Medical
Center, St. Francis Hospital, Stanford University, University of Pittsburgh Medical Center, Edward Cardiovascular Institute,
Michigan Heart Imaging, Ohio Heart, University of Illinois, Arizona Heart Institute, Alfried Krupp Krankenhaus, Essen,
Landeskrankenhaus in Graz, Austria, Cardiology Research Centre in Moscow, Russia, FAU Erlangen-Nurnberg in Erlangen,
Germany, Beijing Hospital in China, HeartScan Imaging, Cooper Clinic, HealthScan of La Jolla, LifeScore of San Diego and
HealthScan of Plano (Dallas).
Except for the historical information contained herein, the matters discussed in this news release may contain forward-looking
statements that are based on current expectations and estimates about the industry in which Imatron operates, the estimated impact
of certain technological advances, the estimated impact of published research studies on scanner sales and procedures, as well as
management's beliefs and assumptions. It is important to note that the Company's actual results could differ materially from those
projected in such forward-looking statements. The factors that could cause actual results to differ materially include, among others;
failed clinical demonstration of certain asserted technological advantages and diagnostic capabilities; reliance on product
distributors; competition in the diagnostic imaging market; failure to improve product reliability or introduce new product models
and enhancements; delays in production and difficulty in obtaining components and sub-assemblies from limited sources of supply;
inability to meet cash-on-delivery or prepayment terms from vendors; determinations by regulatory and administrative government
authorities; patent expiration and denial of patent applications; the high cost of the scanner as compared to commercially available
CT scanners; and the risk factors listed from time to time in the Company's Securities and Exchange Commission reports,
including their reports of Form 10-K for their current fiscal year.
Contact:
Imatron
S. Lewis Meyer, 650/583-9964 (CEO)
Robin Kelley, 650/583-9964 (Investor Relations)
Email this story - View most popular stories emailed
More Quotes and News:
Imatron Inc (NasdaqNM:IMAT - news)
Related News Categories: computer hardware, computers, health care, medical/pharmaceutical
Help
Copyright © 2000 Yahoo! All Rights Reserved. Privacy Policy - Terms of Service
Copyright 2000 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an
individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but
not limited to, posting, emailing, faxing, archiving ina public database, redistributing via a computer network or in a printed form.
Questions or Comments? |
